![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 37, 33559-33563, September 13, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,From the Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom
Received for publication, May 20, 2002, and in revised form, May 31, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Cytochromes c are typically
characterized by the covalent attachment of heme to polypeptide through
two thioether bonds with the cysteine residues of a
Cys-Xaa-Xaa-Cys-His peptide motif. In many Gram-negative
bacteria, the heme is attached to the polypeptide by the
periplasmically functioning cytochrome c maturation (Ccm) proteins. Exceptionally, Hydrogenobacter thermophilus
cytochrome c552, which has a normal
CXXCH heme-binding motif, and variants with
AXXCH, CXXAH, and AXXAH motifs, can
be expressed as stable holocytochromes in the cytoplasm of
Escherichia coli. By targeting these proteins to the
periplasm using a signal peptide, with or without co-expression of the
Ccm proteins, we have assessed the ability of the Ccm system to attach
heme to proteins with no, one, or two cysteine residues in the
heme-binding motif. Only the wild-type protein, with two cysteines, was
effectively processed and thus accumulated in the periplasm as a
holocytochrome. This is strong evidence for disulfide bond formation
involving the two cysteine residues of apocytochrome c as
an intermediate in Ccm-type Gram-negative bacterial cytochrome
c biogenesis and/or that only a pair of cysteines can be
recognized by the heme attachment apparatus.
Cytochromes c are typically characterized
by the covalent attachment of heme to polypeptide through two thioether
bonds with the cysteine residues of a Cys-Xaa-Xaa-Cys-His peptide motif
(1, 2). They are ubiquitous in nature; their primary function is in
electron transfer, but they may also be found at the active sites of
enzymes, and in higher cells they play a role in apoptosis (3-8).
Despite the essential roles of these proteins, it is not clear either
how or why the heme becomes covalently attached to the polypeptide; it
is not covalently bound in most hemoproteins (9). Remarkably, three
different c-type cytochrome biogenesis systems have been
identified to date (1, 2, 10). Gram-negative bacteria use either the
cytochrome c maturation
(Ccm)1 proteins (also called
system I) or a distinct set of proteins known as system II (10). The
Ccm proteins (in Escherichia coli, CcmABCDEFGH; Ref. 11) are
located in the periplasm and/or cytoplasmic membrane; all bacterial
cytochromes c are either periplasmic or on the periplasmic
face of this membrane (1, 2, 10, 12).
It is commonly assumed, but it has not been proven, that formation of a
disulfide bond between the two cysteine residues of apocytochrome
c is an intermediate in bacterial cytochrome c
biogenesis by the Ccm system. The cysteine thiols are thought to be
oxidized to a disulfide by DsbA, one of the proteins of the Dsb
disulfide isomerase system, which actively forms disulfide bonds in the periplasm (2, 13). We have recently shown that a bacterial apocytochrome c can spontaneously form an intramolecular
disulfide bond in oxidizing conditions even in the absence of DsbA
(14). It would be necessary for any intramolecular disulfide in
apocytochrome c to be reduced before the thiols can react
with the vinyl groups of heme. CcmG and CcmH both contain the
thioredoxin motif (CXXC) of disulfide reductases (13); at
least one of them has been argued to reduce the cysteines of
apocytochrome c before heme attachment, ultimately by
transferring electrons from DsbD (also known as DipZ) (13, 15).
DsbD receives electrons from the cytoplasmic TrxA and transfers
them to the periplasm. Mutants of E. coli deficient in DsbA,
DsbB (the oxidant for DsbA), DsbD, or TrxA were all unable to
synthesize c-type cytochromes (16-18). However, it is not
clear whether this was because of the inability of these mutants to
process a disulfide involving apocytochrome c, one or more
of the Ccm proteins, or indeed a combination of these proteins. The
importance of investigating whether the substrate, i.e.
cytochrome c, or the biogenesis apparatus requires disulfide bonds is emphasized by work on the type II secretion system in Gram-negative bacteria (19). The requirement for DsbA was initially taken to mean that a secreted protein needed a disulfide bond; later it
was shown that the disulfide was required in the biogenesis machinery and that a modified substrate could be secreted with a single
cysteine thiol instead of a disulfide between two cysteines (19).
It is important for understanding the operation of the Ccm system to
determine whether it can assemble cytochromes c in which the
heme is attached to the apoprotein by only one thioether bond. Among
other things, this would provide strong evidence as to whether an
intramolecular disulfide bond in an apocytochrome c is
indeed an intermediate. Ríos-Velázquez et al.
(20) made single and double cysteine to alanine substitutions in the
heme-binding motif of Rhodobacter sphaeroides cytochrome
c2. Such variant proteins were unable to support
growth via photosynthesis where functional cytochrome
c2 is required. However, in their experiments,
no product cytochromes with these substitutions, either holo or apo
forms, could be isolated. This indicates that the proteins produced
were unstable and rapidly degraded in vivo; thus it is not
possible to say definitely whether or not the heme was covalently
attached to the polypeptides by the Ccm proteins of R. sphaeroides before degradation occurred. Sambongi et
al. (21) conducted similar experiments using heme-binding motif
variants of Paracoccus denitrificans cytochrome
c550, but again the products were unstable.
Unusually heme may be covalently (and correctly) attached to cytochrome c552 from Hydrogenobacter
thermophilus in the cytoplasm of E. coli apparently
without the action of any specialized biosynthesis proteins (22-24).
Replacement of one or both of the heme-binding cysteine residues by
alanines (C11A, C14A, and C11A/C14A) also results in formation of
stable cytochromes (25, 26). In the two former cases, the heme is
covalently attached to the polypeptide through a single thioether bond;
in the latter the product is a b-type cytochrome whose heme
is noncovalently bound to the polypeptide. Therefore, we have used
H. thermophilus cytochrome c552 and
the C11A, C14A, and C11A/C14A variants to investigate the functioning of the Ccm system. Each of the proteins has been targeted to the periplasm of E. coli where the Ccm proteins act and
expressed with or without plasmid-borne ccm genes.
E. coli strain JCB387 (27) was transformed with an
appropriate plasmid encoding for H. thermophilus cytochrome
c552, C11A, C14A, or C11A/C14A variants. Two
forms of these plasmids were used; plasmids pKHC12 (22), pEST201,
pEST202, and pEST203 (25, 26) with no periplasmic signal sequence,
resulting in cytoplasmic expression of the cytochromes, have been
described previously. New plasmids were constructed with the signal
sequence of Pseudomonas aeruginosa cytochrome
c551 to target the apocytochromes to the periplasm. PCR was used to amplify and fuse the signal sequence gene to
the cytochrome gene on plasmids pKHC12, pEST201, pEST202, and pEST203
using the same method as Zhang et al. (28). pEST210, which
carries wild-type cytochrome c552 and the signal
sequence, was the kind gift of Dr. Y. Sambongi. Each of these new
plasmids was sequenced to ensure that the signal sequence was present
and that there were no secondary mutations in the cytochrome gene. Cells could also be co-transformed with pEC86 (29), which carries the
E. coli cytochrome c maturation genes
ccmABCDEFGH. E. coli cytochrome
b562 with a periplasmic targeting sequence was
produced using a plasmid described previously (30);
b562 cell cultures were grown identically to
those transformed with the other plasmids, and the plasmid-borne
ccm genes were co-transformed as required.
Cells were initially grown on LB-agar plates with the appropriate
antibiotics (100 µg ml Cytochrome content was determined by recording absorption spectra of
the crude periplasmic and cytoplasmic fractions to which a few grains
of solid disodium dithionite had been added. Concentrations (and hence
the quantity of cytochrome per gram of wet cells) were determined using the characteristic absorbance wavelengths and extinction coefficients described below for reduced H. thermophilus cytochrome c552 and variants.
Note, however, that is was necessary to correct absorbance measurements
of cell extracts because of the presence of endogenous E. coli cytochromes (see "Results"). For the wild-type H. thermophilus cytochrome c552, Since all the cytochrome-encoding plasmids conferred ampicillin
resistance, cell fractions were assayed for periplasmic proteins using
E. coli strain JCB387 was transformed with various
plasmids to assess the ability of the E. coli cytochrome
c maturation proteins to process wild-type H. thermophilus cytochrome c552 and C11A, C14A, and C11A/C14A variants; these have CXXCH,
AXXCH, CXXAH, and AXXAH heme-binding
motifs, respectively. Each of these four proteins was available with or
without a periplasmic targeting sequence. The latter enables
translocation of the polypeptide to the periplasm where the Ccm system
operates. Thus, in our investigations, 16 combinations were used:
cytochrome c552, C11A, C14A, and C11A/C14A ± a periplasmic signal sequence, each ± the plasmid-borne
ccm genes. E. coli strain JCB387 (27) was chosen
because preliminary experiments indicated that it produced only
moderate yields of each of the four H. thermophilus
cytochromes cytoplasmically (i.e. in the absence of the
targeting sequence the cytochrome production was detectable but not
such as to swamp any periplasmic cytochromes that may be produced with
a targeting sequence). Strain JCB387 also produced a poor yield of
periplasmically targeted wild-type cytochrome
c552 in the absence of the co-transformed
ccm plasmid. Cells were grown aerobically, so that
expression of the endogenous Ccm system of E. coli would be
minimized, and were fractionated into periplasmic and
cytoplasmic components; each fraction was assayed for contamination by
the other using enzyme marker assays. The fractionation protocol was
carefully optimized to result in minimal contamination of the
periplasmic fraction with cytoplasmic proteins and vice versa (see
"Experimental Procedures"). Quantities of cytochrome produced were
determined spectrophotometrically.
In the absence of a periplasmic signal sequence, effectively 100% of
each of the cytochromes was made cytoplasmically (Table I).2
These data were as anticipated and serve both as a control experiment and as a reference against which expression with a periplasmic signal
sequence can be assessed. In the presence of the signal sequence, of cytochrome c552 and each of the
three variants studied, only the wild-type holoprotein was found in
significant quantities in the periplasm. With the signal sequence and
the ccm plasmid present, essentially 100% of the wild-type
cytochrome was periplasmic (Table II). In
contrast, the variant cytochromes were found in the periplasm only in
small amounts even when the Ccm proteins were co-expressed (in each
case less than 5% of the total cytochrome after subtraction for
cytoplasmic contamination and endogenous cytochrome production by
E. coli (see below)). In the presence of the periplasmic
targeting sequence, with or without the ccm plasmid, there
was no significant quantitative difference in the total expression
level or periplasmic quantities of the AXXAH, CXXAH, or AXXCH proteins (Table II). Small
quantities of variant proteins in the periplasm can be accounted for by
self-assembly; if protein with a signal sequence is translocated to the
periplasm and encounters heme, it can be expected to spontaneously form a cytochrome as it does in the cytoplasm.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1 ampicillin in each case plus 34 µg ml
1 chloramphenicol where pEC86 was co-transformed).
Single colonies were picked into 500-ml 2× TY medium (16 g
liter
1 peptone, 10 g liter
1 yeast extract, 5 g
liter
1 NaCl) supplemented with 1 mM
isopropyl-1-thio-
-D-galactopyranoside in 3-liter
flasks. Cultures were grown at 37 °C with shaking at 200 rpm for
20-24 h before harvesting. Cell pellets were washed with cold 10 mM Tris-HCl, pH 7.3, 150 mM NaCl. The cells
were then centrifuged again, and the cell pellets were weighed and resuspended in 15 ml of SET buffer (0.5 M sucrose, 200 mM Tris-HCl, pH 7.3, 1 mM EDTA). 15 mg of
lysozyme was added, immediately followed by 15 ml of ice-cold water to
administer a mild osmotic shock. This mixture was incubated at 37 °C
for 30 min and then centrifuged at 9000 × g for 15 min. The supernatant was retained as the periplasmic fraction. The
pellet was resuspended in 15 ml of water, sonicated vigorously on ice,
and centrifuged at 39,000 × g for 45 min. The supernatant at this stage was taken to be the cytoplasmic fraction.
= 182 or 27.7 mM
1 cm
1 at 417 or
552 nm, respectively; for the C11A variant,
= 179.5 or 27.7 mM
1 cm
1 at 422 or 557 nm,
respectively; for the C14A variant,
= 174.5 or 29.8 mM
1 cm
1 at 420 or 556 nm,
respectively; for the C11A/C14A variant,
= 145 or 27.3 mM
1 cm
1 at 425 or
560 nm, respectively. The extinction coefficients for the wild-type and
single cysteine cytochromes were determined by recording absorption
spectra of highly purified protein whose absolute concentration had
been determined by total amino acid analysis. The extinction
coefficients for the C11A/C14A protein were determined from pyridine
hemochrome assays (31). Activity staining of SDS-polyacrylamide gels
for covalently bound heme was conducted using the method of Goodhew
et al. (32).
-lactamase activity (33). To 980 µl of 50 mM potassium phosphate buffer, pH 7.0 in a quartz cuvette, 10 µl of 100 mg ml
1 ampicillin and 10 µl of cell extract were added.
Absorbance change at 244 nm was recorded; note that it was necessary
(and appropriate) to directly compare only the activity, normalized for
volume, observed for the periplasmic and cytoplasmic fractions from a particular culture fractionation. Cytoplasmic proteins were assayed using malate dehydrogenase activity (34, 35). To 970 µl of 50 mM potassium phosphate buffer, pH 7.0, 10 µl of 25 mM
-NADH and 10 µl of cell extract were added. The
reaction was initiated by the addition of 10 µl of 20 mM
oxaloacetate as substrate. Absorbance decrease at 340 nm was monitored
to relate the activity observed for the volume-normalized periplasmic
and cytoplasmic fractions from a particular culture.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Distribution in E. coli of H. thermophilus cytochrome c552 and
variants with altered heme-binding motifs expressed from genes
lacking signal sequences
-lactamase and malate dehydrogenase, respectively. The percentage of
the total cytochrome in the periplasm and the yield of total cytochrome
per gram of wet cells are corrected from the raw measurements by
subtracting a constant background level of endogenous E. coli cytochromes (see "Results").
Distribution in E. coli of H. thermophilus cytochrome c552,
variants with altered heme-binding motifs, and E. coli cytochrome
b562, expressed from genes with signal sequences
-lactamase and
malate dehydrogenase, respectively. The percentage of the total
cytochrome in the periplasm and the yield of total cytochrome per gram
of wet cells are corrected from the raw measurements by subtracting a
constant background level of endogenous E. coli cytochromes
(see "Results"). cyt., cytochrome.
Within experimental error, targeting the apocytochromes to the periplasm caused a decrease in total holocytochrome production in every case except for the wild-type cytochrome c552 when co-expressed with the Ccm proteins (compare data in Table II with data in Table I). Moreover, the results in Table II (and described above) show that the vast majority of the periplasmically targeted holocytochromes with substitutions in the heme-binding motif were made cytoplasmically despite the presence of the signal sequence. Staining SDS-polyacrylamide gels for covalently bound heme for such periplasmically targeted c552 variants resulted in a band at a higher molecular weight than for cytoplasmically produced protein with no targeting sequence, reflecting the presence of both heme and the targeting sequence in the higher molecular weight material. It might be anticipated that the availability of the periplasmic signal sequence would cause rapid translocation of the apoprotein before heme attachment could occur in the cytoplasm. However, our data indicate that there is competition between the rate of heme binding to apoprotein in the cytoplasm and the rate of apoprotein translocation to the periplasm by the general type II secretion (Sec) proteins. Translocation may be slowed because H. thermophilus apocytochromes c552 are quite structured (36), and the Sec system transports unfolded proteins (37).
The observation that the periplasmically targeted double alanine (C11A/C14A) variant protein, which forms a b-type cytochrome (25), was not made in significant quantities in the periplasm, either with or without the Ccm system, is an apparent anomaly. In our experimental conditions, E. coli cytochrome b562 with a periplasmic signal sequence was made effectively 100% periplasmically with or without co-expression of the ccm plasmid (Table II). It is well established that disruption of the Ccm proteins does not inhibit b562 formation in the periplasm of E. coli (38, 39); hence we anticipated that C11A/C14A c552 would be made equally well. One plausible explanation for our observations is that, when in the periplasm, the apo form of the C11A/C14A protein, which is not a naturally occurring b-type cytochrome, acquires its heme less quickly than and/or is more susceptible to proteolysis than apocytochrome b562. This would not affect the wild-type cytochrome c552, which can rapidly acquire heme from the Ccm system. The means by which b-type cytochromes acquire heme in the bacterial periplasm, a compartment of the cell in which they are rare, is far from understood, so the specific nature of the apocytochrome may, therefore, also be important for the process.
When wild-type cytochrome c552 was expressed with the periplasmic signal sequence but no ccm plasmid, a significant fraction of the c552 was found in the periplasmic fraction (on average ~60%). This suggests that the endogenous E. coli Ccm system, which is maximally expressed under anaerobic conditions (40), was being expressed to some extent during growth (i.e. our cultures were not fully aerobic). However, even with this level of expression of periplasmic cytochrome c552, the yield in mg of periplasmic cytochrome produced per g of wet cells was only ~14% of that produced when the ccm plasmid was present; thus this effect is relatively minor. As a corollary, wild-type c552 with a periplasmic signal sequence but no ccm plasmid produced ~40% cytoplasmic cytochrome c, whereas in the equivalent case with the ccm plasmid, the latter value was ~0%. Furthermore, any low level expression of the cells' own Ccm proteins has not affected our data for the cytochromes with substitutions in the heme-binding motif since the introduction of the ccm plasmid (which implies a much higher level of expression) makes no significant quantitative difference to the periplasmic cytochrome expression levels of these variant proteins.
To determine background absorbances in our measurements, we assessed
the level of endogenous cytochrome production by E. coli strain JCB387 not transformed with any of our plasmids. In the periplasmic fractions of such cells, we detected a c-type
cytochrome (
max, 551 and 419 nm), probably NapB, a
soluble subunit of the periplasmic nitrate reductase (41). In the
cytoplasm we detected absorbance from one or more hemoproteins
(observed
max, ~560 and ~423 nm), e.g.
catalase. The periplasmic cytochrome accounted for 33% of the total
absorbance, and the cytoplasmic cytochrome(s) accounted for 67% with
the periplasmic and cytoplasmic fractions normalized for volume. These
proportions were essentially the same (32 and 68%) if E. coli JCB387 was transformed with the ccm plasmid pEC86
but no exogenous cytochrome plasmid. One might expect that expression
of the Ccm proteins from the plasmid would stimulate production of the
endogenous periplasmic c-type cytochrome. However, the
nap and ccm operons are co-regulated in E. coli (11, 42), so in a given set of growth conditions, the
expression of NapB would be limited by the same factor(s) with or
without co-expression of the Ccm proteins from pEC86. We have corrected
for these background hemoprotein absorbances in Tables I and II
assuming that the endogenous cytochromes were produced at the same
levels per gram of wet cells in all of our growth experiments; the
effect is to reinforce the conclusions drawn in the paragraphs above.
The percentages of each of the variant cytochromes (AXXCH,
CXXAH, or AXXAH heme-binding motifs) in our
periplasmic fractions are lowered because some of the absorbance
attributed to these proteins in the raw measurements was in fact due to
endogenous cytochrome(s).
| |
DISCUSSION |
|---|
|
|
|---|
The principal result of this study is that the type I cytochrome c maturation system as found in many Gram-negative bacteria can only effectively process covalent heme attachment to apocytochrome c with two cysteine residues in the heme-binding motif. The nature of our experiments is such that we cannot say with certainty that the activity of the Ccm system toward the substrate apoproteins with single or no cysteine heme-binding motifs is 0%, rather than <2%, of that with the double cysteine apocytochrome; nevertheless, the latter value is a reasonable estimate of the upper limit of any such activity. The implication is that an intramolecular disulfide bond within apocytochrome c is, as postulated on the basis of less direct evidence, an intermediate in this type of cytochrome c biogenesis. This idea finds support in the observation that H. thermophilus apocytochrome c552 forms an intramolecular disulfide bond under oxidizing conditions following removal of the heme in vitro (14). An alternative explanation for the data presented in the present work is that that both apocytochrome cysteine thiols play specific, and required, roles in the maturation pathway, possibly involving intermolecular disulfide bonds. A further interpretation, which may or may not be combined with the obligate formation of one or more disulfide bonds, is that the ultimate highly specific recognition determinant for heme attachment by the Ccm system is the two cysteine thiols in the apocytochrome heme-binding motif. Note, however, that any rationalization of our data must allow for the fact that the Ccm proteins are active with substrate apocytochromes that either have naturally (43), or have as the result of amino acid substitutions (20), CXXXXCH or CXXXCH heme binding-motifs, and thus it is the two cysteines that are important rather than their precise spatial arrangement.
It is very possible that the CXXCH motif of apocytochrome c cannot avoid being oxidized to a disulfide in the bacterial periplasm, e.g. by the active oxidant DsbA, and thus that the Ccm system has evolved to handle such oxidized apoproteins. Indeed it has been suggested (13) that formation of a disulfide in the apocytochrome may pre-fold the polypeptide and that this facilitates covalent heme attachment. The likelihood that a disulfide bond is an intermediate in holocytochrome c formation also implies that covalent heme attachment, or formation of a mixed disulfide between one of the apocytochrome cysteines and a cysteine from one of the Ccm proteins, is concerted with reduction of the apocytochrome disulfide. Otherwise the reduced disulfide is susceptible to rapid reoxidation by, for example, DsbA.
The crucial difference between our failure to observe covalent
attachment of heme to apocytochromes with a CXXAH or
AXXCH heme-binding motif and previous related studies (20,
21) is that in the earlier cases the products were unstable with
respect to degradation. Thus is was not possible to determine
unequivocally whether heme was in fact covalently attached by the
bacterial Ccm system before the protein degraded. Moreover, there is no evidence that single cysteine proteins with covalently bound heme could
ever actually form from the variant apocytochromes tested in the
earlier studies. In the present work, we have used H. thermophilus cytochrome c552 together with
mutants that are known to form holocytochromes and to be stable when
expressed in the cytoplasm of E. coli (Table I and Refs. 25
and 26); the wild-type cytochrome is clearly also stable in the
periplasm (Table II). Thus, our inability to observe variant
holocytochromes in significant quantities in the periplasm is
convincing evidence that the Ccm system cannot covalently attach heme
to apocytochromes that do not have two cysteine residues in the
heme-binding motif. Previous studies have shown that apocytochrome c with a periplasmic signal sequence, even with
substitutions in the heme-binding motif, is translocated into the
periplasm independent of the heme attachment process (21). Single
cysteine-attached cytochromes (XXXCH motif) have been
isolated from some eukaryotic sources (44-47). In two cases (46, 47)
the formation of these cytochromes was catalyzed by a specific enzyme,
cytochrome c heme lyase from yeast mitochondria, but the
yields were low relative to protein with a CXXCH
heme-binding motif. It may be that other mitochondrial heme lyases have
evolved where necessary to cope with only having one thiol for heme
attachment. No single cysteine-attached cytochromes c have
been observed to date in bacteria, which is consistent with the
inability of the Ccm system, one of two known bacterial cytochrome
c biogenesis systems (1, 2, 10), to process them. Parts of
the Ccm system appear to function in mitochondria from at least some
plants and from protists such as Reclinomonas americana
(48). If any eukaryote were found to have both the Ccm system and
single cysteine attachment of heme in a cytochrome c, then
the present work would imply that the Ccm system can be modified when
it operates outside bacteria to cope with a single cysteine
heme-binding motif.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. L. Thöny-Meyer for the gift of plasmid pEC86, A. C. Willis for amino acid analyses, and Mark Bushell for helpful discussions.
| |
FOOTNOTES |
|---|
* This work was supported by Biotechnology and Biological Sciences Research Council Grant C13443 (to S. J. F.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The W. R. Miller Junior Research Fellow, St. Edmund Hall, Oxford.
§ To whom correspondence should be addressed. Tel.: 44-1865-275240; Fax: 44-1865-275259; E-mail: ferguson@bioch.ox.ac.uk.
Published, JBC Papers in Press, June 4, 2002, DOI 10.1074/jbc.M204963200
2 Note that subtraction from the percentage of the total cytochrome in the periplasmic fraction (Tables I and II, fourth column) is necessary to correct for contamination of the periplasmic fraction by cytoplasmic proteins as indicated by malate dehydrogenase assays (Tables I and II, fifth column).
| |
ABBREVIATIONS |
|---|
The abbreviation used is: Ccm, cytochrome c maturation.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Thöny-Meyer, L. (2000) Biochim. Biophys. Acta 1459, 316-324[Medline] [Order article via Infotrieve] |
| 2. | Page, M. D., Sambongi, Y., and Ferguson, S. J. (1998) Trends Biochem. Sci. 23, 103-108[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Moore, G. R., and Pettigrew, G. W. (1990) Cytochromes c: Evolutionary, Structural, and Physicochemical Aspects , Springer-Verlag, New York |
| 4. | Pettigrew, G. W., and Moore, G. R. (1987) Cytochromes c: Biological Aspects , Springer-Verlag, New York |
| 5. | Scott, R. A., and Mauk, A. G. (1995) Cytochrome c: A Multidisciplinary Approach , University Science Books, Mill Valley, CA |
| 6. | Einsle, O., Messerschmidt, A., Stach, P., Bourenkov, G. P., Bartunik, H. D., Huber, R., and Kroneck, P. M. (1999) Nature 400, 476-480[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Igarashi, N., Moriyama, H., Fujiwara, T., Fukumori, Y., and Tanaka, N. (1997) Nat. Struct. Biol. 4, 276-284[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Martinou, J. C., Desagher, S., and Antonsson, B. (2000) Nat. Cell Biol. 2, E41-43[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Barker, P. D., and Ferguson, S. J. (1999) Struct. Fold. Des. 7, R281-R290[Medline] [Order article via Infotrieve] |
| 10. | Kranz, R., Lill, R., Goldman, B., Bonnard, G., and Merchant, S. (1998) Mol. Microbiol. 29, 383-396[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Thöny-Meyer, L.,
Fischer, F.,
Kunzler, P.,
Ritz, D.,
and Hennecke, H.
(1995)
J. Bacteriol.
177,
4321-4326 |
| 12. | Thöny-Meyer, L. (1997) Microbiol. Mol. Biol. Rev. 61, 337-376[Abstract] |
| 13. | Fabianek, R. A., Hennecke, H., and Thöny-Meyer, L. (2000) FEMS Microbiol. Rev. 24, 303-316[CrossRef][Medline] [Order article via Infotrieve] |
| 14. |
Daltrop, O.,
Allen, J. W. A.,
Willis, A. C.,
and Ferguson, S. J.
(2002)
Proc. Natl. Acad. Sci. U. S. A.
99,
7872-7876 |
| 15. | Reid, E., Cole, J., and Eaves, D. J. (2001) Biochem. J. 355, 51-58[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Sambongi, Y., Crooke, H., Cole, J. A., and Ferguson, S. J. (1994) FEBS Lett. 344, 207-210[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Metheringham, R., Tyson, K. L., Crooke, H., Missiakas, D., Raina, and Cole, J. A. (1996) Mol. Gen. Genet. 253, 95-102[Medline] [Order article via Infotrieve] |
| 18. | Reid, E., Eaves, D. J., and Cole, J. A. (1998) FEMS Microbiol. Lett. 166, 369-375[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Pugsley, A. P.,
Bayan, N.,
and Sauvonnet, N.
(2001)
J. Bacteriol.
183,
1312-1319 |
| 20. | Ríos-Velázquez, C., Cox, R. L., and Donohue, T. J. (2001) Arch. Biochem. Biophys. 389, 234-244[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Sambongi, Y., Stoll, R., and Ferguson, S. J. (1996) Mol. Microbiol. 19, 1193-1204[Medline] [Order article via Infotrieve] |
| 22. | Sambongi, Y., and Ferguson, S. J. (1994) FEBS Lett. 340, 65-70[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Karan, E. F., Russell, B. S., and Bren, K. L. (2002) J. Biol. Inorg. Chem. 7, 260-272[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Sinha, N., and Ferguson, S. J. (1998) FEMS Microbiol. Lett. 161, 1-6[CrossRef][Medline] [Order article via Infotrieve] |
| 25. |
Tomlinson, E. J.,
and Ferguson, S. J.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
5156-5160 |
| 26. |
Tomlinson, E. J.,
and Ferguson, S. J.
(2000)
J. Biol. Chem.
275,
32530-32534 |
| 27. | Hussain, H., Grove, J., Griffiths, L., Busby, S., and Cole, J. (1994) Mol. Microbiol. 12, 153-163[Medline] [Order article via Infotrieve] |
| 28. | Zhang, Y., Arai, H., Sambongi, Y., Igarashi, Y., and Kodama, T. (1998) J. Ferment. Bioeng. 85, 346-349[CrossRef] |
| 29. | Arslan, E., Schulz, H., Zufferey, R., Kunzler, P., and Thöny-Meyer, L. (1998) Biochem. Biophys. Res. Commun. 251, 744-747[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Trower, M. K. (1993) Biochim. Biophys. Acta 1143, 109-111[Medline] [Order article via Infotrieve] |
| 31. | Bartsch, R. G. (1971) Methods Enzymol. 23, 344-363 |
| 32. | Goodhew, C. F., Brown, K. R., and Pettigrew, G. W. (1986) Biochim. Biophys. Acta 852, 288-294[CrossRef] |
| 33. | Jansson, J. A. T. (1965) Biochim. Biophys. Acta 99, 171-172 |
| 34. | Page, M. D., and Ferguson, S. J. (1989) Mol. Microbiol. 3, 653-661[CrossRef][Medline] [Order article via Infotrieve] |
| 35. | Le Rudulier, D., Gloux, K., and Riou, N. (1991) Biochim. Biophys. Acta 1061, 197-205[Medline] [Order article via Infotrieve] |
| 36. |
Wain, R.,
Pertinhez, T. A.,
Tomlinson, E. J.,
Hong, L.,
Dobson, C. M.,
Ferguson, S. J.,
and Smith, L. J.
(2001)
J. Biol. Chem.
276,
45813-45817 |
| 37. | Sanders, C., Wethkamp, N., and Lill, H. (2001) Mol. Microbiol. 41, 241-246[CrossRef][Medline] [Order article via Infotrieve] |
| 38. | Throne-Holst, M., Thöny-Meyer, L., and Hederstedt, L. (1997) FEBS Lett. 410, 351-355[CrossRef][Medline] [Order article via Infotrieve] |
| 39. |
Goldman, B. S.,
Gabbert, K. K.,
and Kranz, R. G.
(1996)
J. Bacteriol.
178,
6338-6347 |
| 40. | Iobbi-Nivol, C., Crooke, H., Griffiths, L., Grove, J., Hussain, H., Pommier, J., Mejean, V., and Cole, J. A. (1994) FEMS Microbiol. Lett. 119, 89-94[CrossRef][Medline] [Order article via Infotrieve] |
| 41. | Potter, L. C., and Cole, J. A. (1999) Biochem. J. 344, 69-76 |
| 42. | Grove, J., Tanapongpipat, S., Thomas, G., Griffiths, L., Crooke, H., and Cole, J. (1996) Mol. Microbiol. 19, 467-481[CrossRef][Medline] [Order article via Infotrieve] |
| 43. | Herbaud, M.-L., Aubert, C., Durand, M.-C., Guerlesquin, F., Thöny-Meyer, L., and Dolla, A. (2000) Biochim. Biophys. Acta 1481, 18-24[CrossRef][Medline] [Order article via Infotrieve] |
| 44. | Pettigrew, G. W., Leaver, J. L., Meyer, T. E., and Ryle, A. P. (1975) Biochem. J. 147, 291-302[Medline] [Order article via Infotrieve] |
| 45. |
Priest, J. W.,
and Hajduk, S. L.
(1992)
J. Biol. Chem.
267,
20188-20195 |
| 46. |
Tanaka, Y.,
Kubota, I.,
Amachi, T.,
Yoshizumi, H.,
and Matsubara, H.
(1990)
J. Biochem.
108,
7-8 |
| 47. | Rosell, F. I., and Mauk, A. G. (2002) Biochemistry 41, 7811-7818[CrossRef][Medline] [Order article via Infotrieve] |
| 48. |
Spielewoy, N.,
Schulz, H.,
Grienenberger, J. M.,
Thöny-Meyer, L.,
and Bonnard, G.
(2001)
J. Biol. Chem.
276,
5491-5497 |
This article has been cited by other articles:
![]() |
E. M. Harvat, J. M. Stevens, C. Redfield, and S. J. Ferguson Functional Characterization of the C-terminal Domain of the Cytochrome c Maturation Protein CcmE J. Biol. Chem., November 4, 2005; 280(44): 36747 - 36753. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. A. Allen, P. D. Barker, and S. J. Ferguson A Cytochrome b562 Variant with a c-Type Cytochrome CXXCH Heme-binding Motif as a Probe of the Escherichia coli Cytochrome c Maturation System J. Biol. Chem., December 26, 2003; 278(52): 52075 - 52083. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Stevens, O. Daltrop, C. W. Higham, and S. J. Ferguson Interaction of Heme with Variants of the Heme Chaperone CcmE Carrying Active Site Mutations and a Cleavable N-terminal His Tag J. Biol. Chem., May 30, 2003; 278(23): 20500 - 20506. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |